In our continuous efforts to better serve our patients, Child Vision Center purchased a new Canon Autorefractor Keratometer in May. This computer-controlled machine will measure how light changes as it enters the patient’s eye. By utilizing this advanced technology, the new machine will provide wider and more objective measurements for glasses and contact lens prescriptions.
Child Vision Center is proud to announce another successful international fellowship, completed in April, with Sonya-Kay Forbes, M.B.B.S., of Jamaica. During her time with us, Dr. Forbes attended the 2016 AAPOS annual meeting in Vancouver, British Columbia. She plans to be the first pediatric ophthalmologist in Kingston, Jamaica.
We are completing our second Child Vision Center/Alcon (a Novartis company) international fellowship. The three-month fellowship, generously funded by Alcon, allows an ophthalmologist from another country the opportunity to observe and learn more about patient care, surgery, diagnostic testing and research with the doctors of Child Vision Center. Ibrahim Matende, MD, of Mombassa, Kenya, and Nguyen Van Huy, MD, of Hanoi, Vietnam, have reported learning greatly from their experiences with the opportunity to return to their countries where they will treat patients and teach others. Applications for the next fellowship are currently being reviewed.
The doctors of the Child Vision Center are launching a study to examine a potential role for eyelid hygiene as a preventative measure for the signs and symptoms of blepharitis, a common inflammatory condition of eyelids. This condition causes bothersome symptoms resulting in discomfort for patients, school days lost, and potentially avoidable health care costs. The study aims to determine the potential need by the medical community to promote prophylactic eyelid hygiene, resulting in less symptoms, fewer work and school days lost, and savings of medical dollars.
The doctors of Child Vision Center have been a part of two major publications related to the use of Bevacizumab. Dr. Hunt was a primary investigator, and Drs. Hunt, Norman and Packwood served on the executive committee for this breakthrough study that is revolutionizing the way we treat infants with potentially blinding eye disease (retinopathy of prematurity). The original article was published in "The New England Journal of Medicine." The National Center for Biotechnology Information has the second article.